06/03/2007 (Agence Europe) - In an open letter published on 1 March, Italian GUE MEP Luisa Morgantini welcomes the launch, through the Drugs for Neglected Diseases initiative (DNDi) and the Sanofi-Aventis laboratory, of a new anti-malarial therapy, which combines artemisinin and amodiaquine, and costs €1 per treatment. To ensure that the world's poorest can have access to this treatment, the laboratory has not patented the medicine, thus allowing the poorest countries to produce and...